Recently Viewed

  • Home
  • Stories
  • News Announcement
  • Aspira Pathlab & Diagnostics: Board Meeting Intimation for Approval Of Audited Standalone Financial Results Of The Company Along With The Auditor Report As On March 31 2026
News Announcement

Aspira Pathlab & Diagnostics: Board Meeting Intimation for Approval Of Audited Standalone Financial Results Of The Company Along With The Auditor Report As On March 31 2026

18-May-2026 Follow Value Research Online on Google download pdfDownload PDF Aspira Pathlab

Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 inter alia to consider and approve Audited Standalone Financial Results of the Company alongwith the Auditor Report as on March 31 2026 & to transact other businesses with the permission of Chair.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds